best prescription alternatives to ozempic glp-1 agonists The European Medicines Agency has recommended the first oral treatment for weight management, offering an alternative weekly injections. Find out more in link in bio! #OneHealthEU #EMA FDA approves Foundayo, an oral
Description
obesity vs

Obesity is a risk factor for poor overall health, reduced functional capacity, decreased quality of life and is associated with a myriad of chronic conditions

The GLP-1 system has emerged as a key integrative node linking metabolic regulation and neurobiological mechanisms of reward

Jones MR, Hall OM, Kaye AM, Kaye AD

These clinicians make prescribing decisions based on their independent professional judgment
March 2024
